36
The 2009 NBCUS: Where we were then and Where we were then and where we are going Barbee I. Whitaker, Ph.D. Director, Center for Data & Special Programs AABB AABB www.aabb.org www.aabb.org

The 2009 NBCUS - UCLA Healthpathology.ucla.edu/workfiles/Education/Transfusion... · 2012. 7. 2. · 2009 New (or better) Questions • Blood Collection and donation • Apheresis

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • The 2009 NBCUS: Where we were then andWhere we were then and 

    where we are going

    Barbee I. Whitaker, Ph.D.Director, Center for Data 

    & Special ProgramsAABBAABB

    www.aabb.orgwww.aabb.org

  • Background

    • Office of the Assistant Secretary of Health, HHS / AABB

    • Critical data for transfusion medicine community– Data year 2008

    • Continuity allows trending:– 2004, 2006, 2008– 1997, 1999, 2001

    www.aabb.org

  • Design and ReviewDesign and Review

    • AABB NBCUS Committee– Bill Coenen, ABC – Nina Salomon, BCA– Roger Dodd, PhD (ARC)Roger Dodd, PhD (ARC)– Jim AuBuchon, MD (Dartmouth/PSBC)– Alyssa Ziman, MD (UCLA/ASH)– Scott Brubaker (AATB)Scott Brubaker (AATB)– Alan Williams, PhD (FDA)– Matthew Kuehnert, MD (CDC)– George Schreiber, ScD (Westate)George Schreiber, ScD (Westate)

    www.aabb.org

  • Survey InstrumentSurvey Instrument

    • Bi‐modal Survey Instrument sent to 3 161• Bi‐modal Survey Instrument sent to 3,161 hospitals and 135 blood centers nationwide– 20 page paper questionnairep g p p q

    • Separate 6 page paper secondary (CT) questionnaire

    – Web survey – imbedded logic• 78% (hospitals) – 87% (blood centers) used the web survey

    • Online response incentive

    www.aabb.org

  • 2009 Survey Population2009 Survey Population

    • Blood Centers– 126/135 (93.3% response rate)

    • Hospitals (AHA/AABB databases)– 1,529/2,970 (51.5% response rate), / , ( p )

    • CT Questionnaire Response– 88/201 (43 8% response rate) + 77 online88/201 (43.8% response rate) + 77 online responses = 165 CT surveys

    www.aabb.org

  • Respondent CharacteristicsRespondent Characteristics

    17% f di bl d t id• 17% of responding blood centers consider themselves centralized transfusion services 

    • 12.4% of responding hospitals collect blood

    www.aabb.org

  • 2009 New (or better) Questions2009 New (or better) Questions• Blood Collection and donation

    • Apheresis collection• Mobile collections• Deferrals/Discards• Deferrals/Discards• Donors

    • UtilizationUtilization• Pediatric• Use by Hospital Service/Department

    • Adverse reactions

    www.aabb.org

  • Total Whole Blood and Red Blood Cell Collections: 1989 - 2008Collections: 1989 2008

    18

    20

    12

    14

    16

    s

    8

    10

    12

    ons

    of U

    nits

    Total

    Allogeneic

    4

    6Mill

    i g

    Autologous

    0

    2

    1989 1992 1994 1997 1999 2001 2004 2006 2008

    Survey Year

    www.aabb.org

    Survey Year

  • Autologous and Directed Whole Blood and R d Bl d C ll C ll i 1989 2008Red Blood Cell Collections: 1989‐20082000

    1400

    1600

    1800

    ands

    800

    1000

    1200

    ts in

     Tho

    usa

    Autologous

    Directed

    200

    400

    600Unit Directed

    0

    1989 1992 1994 1997 1999 2001 2004 2006 2008

    www.aabb.org

  • RBC Apheresis18000

    15000

    18000

    1.9% 5.6%10.2%

    11.3%

    12000

    Units

    0.9%

    6000

    9000

    Thou

    sand

    s of 

    3000

    6000T

    0

    1999 2001 2004 2006 2008

    www.aabb.orgTraditional Allogeneic Collections RBC Apheresis Collections

  • Whole Blood and Red Blood Cell Apheresis CollectionsRed Blood Cell Apheresis Collections

    Type of RBC

    Collection

    2008 2006 PercentChange

    (Δ)Blood Center

    Hospital Total Total( )

    WB Allogeneic

    14,120,000 927,000 15,047,000 14,151,000 6.3%

    WB 172,000 81,000 253,000* 335,000 -24.5%WB Autologous

    172,000 81,000 253,000 335,000 24.5%

    WB Directed 35,000 26,000 61,000* 70,000 -12.8%RBC 1 884 000 41 000 1 926 000 1 619 000 18 9%RBC

    Apheresis1,884,000 41,000 1,926,000 1,619,000 18.9%

    Total 16,212,000 1,074,000 17,286,000 16,174,000 6.9%

    www.aabb.org

  • Whole Blood and d l d ll h llRed Blood Cell Apheresis Collections

    Type of RBC

    Collection

    2008 2006 Per Cent Change

    (Δ) Blood Center

    Hospital Total TotalCenter

    Total 16,212,000 1,074,000 17,286,000 16,174,000 6.9%

    Rejected on 116 000 11 000 127 000 151 000 -15 9%Rejected on Testing

    116,000 11,000 127,000 151,000 -15.9%

    Available 17 159 000 16 023 000 7 1%Available Supply

    17,159,000 16,023,000 7.1%

    www.aabb.org

  • Red Blood Cell TransfusionsRed Blood Cell Transfusions

    Estimated Transfusions by Blood Centers and Hospitalsy pType of RBC Transfusion

    2008 2006 Per Cent Change

    (Δ)Blood C t

    Hospital Total Total(Δ)Center

    Allogeneicnot directed)

    654,000 14,127,000 14,782,000 †* 13,978.000 5.8%

    Autologous 5,000 154,000 159,000 189,000 -15.8%

    Directed 0 73,000 73,000* 126,000 - 41.7%Total 15 014 000 14 650 000† 2 5%Total 15,014,000 14,650,000† 2.5%

    † Total includes pediatric transfusions

    www.aabb.org

  • Allogeneic Whole Blood and Red Blood Cell Collections and TransfusionsCollections and Transfusions

    17.0

    18.0

    15.0

    16.0

    12.0

    13.0

    14.0

    s of

    Uni

    ts

    10.0

    11.0

    12.0

    Mill

    ions Collections

    Transfusions

    Available Collections:

    8.0

    9.0

    1989 1992 1994 1997 1999 2001 2004 2006 2008

    1997-2008

    www.aabb.org

    1989 1992 1994 1997 1999 2001 2004 2006 2008

  • Daily Supply Type O Units

    10

    12

    8

    ply

    4

    6

    Days Supp

    2

    4

    0

    Jan Feb Mar April May June July August Sept Oct Nov Dec

    O + (2008) O ‐ (2008) O + (2009) O ‐ (2009) O + (2010) O ‐ (2010)

    www.aabb.org

  • Key Findings: Blood ManagementKey Findings: Blood Management

    • 18.2% of surveyed hospitals have established18.2% of surveyed hospitals have established ‘bloodless’ surgery programs– Ranging from 5% of hospitals with 100‐999 surgeries through 27.8% of hospitals with greater than 8,000 surgeries per year

    78 8% i t ti t l• 78.8% use intra‐operative autologous recovery therapies– 92% of large hospitals compared with only 38% of the– 92% of large hospitals compared with only 38% of the smallest hospitals offering these services

    www.aabb.org

  • 2008 Donors2008 Donors

    • 19,339,000 donors presented• 10,877,000  successful allogeneic donors

    – 3,165,000 first‐time donors (29.0%)– 7,640,000 repeat donors (70.2%)72 000 directed donors (0 7%)– 72,000 directed donors (0.7%)

    • 11,461,000 donations from repeat donors• 1 5 donations / repeat donor• 1.5 donations / repeat donor

    www.aabb.org

  • Deferrals by Reason DeferredDeferrals by Reason DeferredHigh Risk Behavior 

    Deferrals

    Travel Deferrals7.9%

    2.9%

    Low Hemoglobin59.3%

    Other Medical Deferrals29 9%29.9%

    www.aabb.org

  • Donor HemovigilanceDonor Hemovigilance

    • Severe adverse donor reactions: 16 000Severe adverse donor reactions: 16,000 reported – 0 09% collections– 0.09% collections – 0.09% collection proceduresH it l h d i ifi tl f ti• Hospitals had significantly fewer reactions with automated collections (0.04%) than with 

    l ll ti d (0 10%

  • Key Findings: Other ComponentsKey Findings: Other Components

    • Whole blood derived platelets transfused in pools ofWhole blood derived platelets transfused in pools of five

    • Platelets reported in apheresis platelet equivalentsp p p q• 23,669,000 components transfused (+5% than 2006)

    – 1,300,000 WBD platelets (NS), , p ( )– 1,761,000 Apheresis platelets (+16%*)– 4,484,000 units plasma (+12%*)– 1,109,000 units cryoprecipitate (+12% NS)

    www.aabb.org

  • Platelet Concentrate Dosage Reported by H i l 2008Hospitals 2008

    60

    40

    50

    ospitals

    30

    ntage of ho

    2001 2004 2006 2008

    10

    20

    Perce

    0

    ≤ 5 6 7 8 9 10 > 10

    l l d (i i )

    www.aabb.org

    Platelet concentrate dosage (in units)

  • Platelet Components PreparedPlatelet Components Prepared

    Estimated Collections by Blood Centers and Hospitalsy pType of

    Collection & Other

    2008 2006 Per Cent Difference

    (Δ)Blood C t

    Hospital Total Total& Other Product

    Processed

    (Δ) Center

    WB Derived 358 000 35 000 393,000 399,000 -1.6%WB Derived Platelets

    358,000 35,000 393,000(1,964,000)

    399,000 1.6%

    Apheresis Platelets

    1,906,000 119,000 2,024,000 1,823,000 11.0%PlateletsTotal 2,263,000 154,000 2,417,000 2,222,000 8.8%

    www.aabb.org

  • Platelets TransfusedPlatelets  Transfused

    Estimated Transfusions by Blood Centers and Hospitalsy pType of Product

    Transfused

    2008 2006 Per Cent Difference

    (Δ)Blood C t

    Hospital Total TotalTransfused (Δ) CenterWB Derived

    Platelets 38,000 222,000 260,000

    (1,300,000)216,000

    (1,296,000)20.3%

    Apheresis Platelets

    60,000 1,701,000 1,761,000* 1,515,000 16.2%

    Total 98,000 1,923,000 2,021,000* 1,731,000 16.7%

    www.aabb.org

  • Platelet Transfusions

    2500

    Whole-blood-derived platelet concentrates* Apheresis platelets

    436 256216

    260

    1500

    2000

    thou

    sand

    s)

    1 3911,515

    1,761

    566 506

    1000

    nsfu

    sed

    (in t

    940 1,0031,264

    1,391

    0

    500

    Uni

    ts T

    ran

    01997 1999 2001 2004 2006 2008

    *expressed as apheresis doses

    www.aabb.org

  • Other Components PreparedOther Components Prepared

    Estimated Collections by Blood Centers and HospitalsType of Non-

    RBC2008 2006 Per Cent

    DiffRBC Collection

    Difference (Δ)

    Blood Center

    Hospital Total Total

    Plasma for 5,305,000 395,000 5,700,000 5,684,000 0.3%Transfusion

    , , , , , , , %

    Cryoprecipitate 1,425,000 37,000 1,462,000 1,197,000 22.2%

    Granulocytes 2,258 5,766 61%

    www.aabb.org

  • Transfusion of Non‐Red Blood Cell Components

    Estimated Transfusion by Blood Centers and HospitalsEstimated Transfusion by Blood Centers and HospitalsType of Non-

    RBC T f i

    2008 2006 Per Cent Difference

    (Δ)Blood Hospital Total Total

    Transfusion (Δ) Centerp

    Plasma for Transfusion

    222,000 4,263,000 4,484,000* 4,010,000 11.8%

    Cryoprecipitate 42,000 1,068,000 1,109,000 993,000 11.7%

    Granulocytes 1,013* 1,652 38%y , ,

    www.aabb.org

  • Total Number of Irradiated and Leukoreduced R d C ll U i T f d i 2008Red Cell Units Transfused in 2008

    Units

    Modification 2008 2006 % Change

    Irradiated Red Cells 1,502 1,153 30.3Total Leukocyte-reducedred cells 10,294 8,076 27.5red cells

    Pre-Bedside 10,115 7,886 28.3

    At the Bedside 179 190 -5 8At the Bedside 179 190 -5.8

    www.aabb.org

  • Red Cell Modification Trends

    14000

    16000

    10000

    12000

    ds

    8000

    10000

    ts in

     Tho

    usan

    Red Cell Components Modified by LR

    4000

    6000

    Uni Red Cell Units LR Pre‐Storage Transfused

    Red Cells at Bed‐side Leuko‐Filtered Transfused

    Irraditated Red Cell Units Transfused

    0

    2000

    1999 2001 2004 2006 2008

    www.aabb.org

    1999 2001 2004 2006 2008

  • 2008 RBC Use by Hospital ServiceGeneral Surgery

    11%

    Orthopedic Surgery6%

    Other6%

    Cardiac Surgery7%

    General Medicine28% 7%28%

    Trauma/ER9%

    Hem/Onc15%

    ICU11%

    www.aabb.org

    15%

    Transplant1%OB/GYN

    2%Ped/Neonates

    2%

    Neph/Dialysis2%

  • General Surgery

    2008 Platelet Use by Hospital ServiceGeneral Surgery

    7%Orthopedic Surgery

    1%

    Cardiac SurgeryGeneral Medicine15%

    Other4%

    12%15%

    Trauma/ER3%

    ICU11%

    Neph/Dialysis0%

    Hem/Onc32%OB/GYN

    1%

    Ped/Neonates8%

    www.aabb.orgTransplant

    6%

  • Component Age at Transfusion

    • Red Cells: Mean Unit Age at Transfusion: 18 days• Estimated mean age was 18.2 daysEstimated mean age was 18.2 days• Calculated mean age was 17.9 days• Only 13% of hospitals were able to calculate age at transfusion

    • Platelets• Platelets• Only 11.2% of hospitals were able to calculate age at transfusion

    – Whole Blood Derived:E i d 3 2 d• Estimated mean age was 3.2 days

    • Calculated mean age was 2.9 days– Apheresis:

    • Estimated mean age was 3.2 days• Calculated mean age was 3.1 days

    www.aabb.org

  • HemovigilanceHemovigilance• 60,000 transfusion related adverse eventsR i f d 0 25%• Reaction rate per components transfused 0.25% or 2.5 per 1,000 transfused (2.6/1,000 in 2006)

    • TRALI: 460 reported ‐ 1:51,000 componentsTRALI: 460 reported  1:51,000 components transfused 

    • Most commonly reported category was febrile non hemolytic reactionsnon‐hemolytic reactions– 29,000 reports (1:816 components transfused)

    • Severe adverse donor reactions: 16,000 reported , p(0.09% collections and 0.09% collection procedures) 

    www.aabb.org

  • Adverse Transfusion Reactions

    6000

    7000*

    4000

    5000

    action

    s

    3000

    4000

    umbe

    rs of R

    e

    2006 2008

    1000

    2000N

    *

    *

    *

    0

    Life Threat Reaction

    TRALI Reaction

    TACO Reaction

    Acute Hemolytic

    Delayed Hemolytic

    Allergic Reaction

    Sepsis Reaction

    www.aabb.org

  • Acknowledgements

    • AABB– Malika Cook– Nina Hutchinson

    • HHS– Jerry Holmberg– Richard HenryNina Hutchinson

    – Diane Killion– Steve Kleinman– Aaron Lyss

    Richard Henry– Renee Wilson

    • George Schreiber• Westat, Inc.

    – Erin Looney– Kathy Loper– Pam Lubel– Jackie Malasky

    – Stan  Legum– Jim Greene– Patrick High

    K S hl fJackie Malasky– Tamara Manning– Laurie Munk– Maria Shay

    – Karen Schlumpf– Jane Schulman

    • Fei, Inc.– Z Cui

    – Phil Schiff– Theresa Wiegmann– Alanna Williamson

    – Z. Cui– J. Gu

    www.aabb.org

  • 2009 NBCUS2009 NBCUS 

    HHS  • www.hhs.gov/bloodsafety• [email protected]• 240‐453‐8803AABB 

    bb• www.aabb.org• [email protected]• 301 215 6574• 301‐215‐6574

    www.aabb.org

  • Hospital Cost SummaryHospital Cost Summary• Average hospital cost of a unit of RBCs (8%), 24 hour 

    l f f i (23%) h i l l (5%) dplasma for transfusion (23%), apheresis platelets (5%) and cryo (76%) increased significantly between 2006‐2008.

    • Red Cell Costs were significantly higher in North East and Northwest USPHS Regions (I, II and IX).

    • Overall costs lower in Southeast and South Central USPHS Regions (IV and VII).Regions (IV and VII).

    • Costs were significantly lower in the largest hospitals for all components surveyed.H it l b t 1 400 2 399 id i ifi tl f• Hospitals between 1,400‐2,399 paid significantly more for cryo.

    www.aabb.org